NextGen Healthcare and Nipro Diagnostics Forge Partnership to Help Diabetes Care Providers and Patients Enhance Care

NextGen Healthcare and Nipro Diagnostics Forge Partnership to Help Diabetes Care Providers and Patients Enhance Care

NextGen HealthcareMichelle Rovner, 215-657-7010

a wholly owned subsidiary of . (NASDAQ: QSII) and a leading provider of healthcare information systems and connectivity solutions, announced today it has entered into an agreement with Nipro Diagnostics, Inc. to integrate its TRUEresult blood glucose monitoring system into the .

This partnership provides NextGen Ambulatory EHR users instant access to data points captured by patients at home who are using the Nipro TRUEresult blood glucose monitoring system. Physicians will gain an immediate benefit from seamlessly performing diagnostic tests with direct entry of information into a patient’s chart. This eliminates the need to manually re-enter patient data while streamlining processes, reducing data entry errors and increasing efficiencies.

The Nipro Diagnostic Blood Glucose interface imports blood glucose readings from the TRUEresult device into NextGen Healthcare’s Ambulatory EHR, allowing users to view and graph the information captured. The NextGenNipro Glucose Meter Interface enables electronic downloading of glucose measurements from a Nipro Diagnostics blood glucose meter into the EHR, automatically populating the appropriate templates and fields, where data can be viewed and analyzed by a physician.

“As a manufacturer of Blood Glucose Monitoring products, our mission is to make it easier for professionals and patients to better manage diabetes care,” said Teri Sasse, RN, MS of Nipro Diagnostics. “By leveraging our partnership with NextGen Healthcare, professionals can use a single program to streamline access to blood glucose readings from our TRUEresult system. This important data can be more quickly and easily analyzed and used to provide feedback to patients to improve their diabetes management and overall health.”

“Home monitoring will become even more important as healthcare providers move toward Patient-Centered Medical Home and Accountable Care Organization (ACO) models,” said Scott Decker, president of NextGen Healthcare. “Seamlessly integrating data directly from a patient’s meter into NextGen Healthcare’s Ambulatory EHR provides physicians with the necessary tools to better manage the health of their patients with chronic disease while also affording them the ability to reduce hospitalizations and improve quality of life. This allows patients to stay at home healthier and longer before requiring interventions.”

Based in Fort Lauderdale, Nipro Diagnostics, Inc. is a leading developer, manufacturer and marketer of diabetes management products. The company offers a portfolio of high-quality blood glucose monitoring systems and products available around the world. Nipro Diagnostics is the exclusive supplier of blood glucose monitoring systems, co-branded under the TRUE name. For more information, visit .

NextGen Healthcare Information Systems, LLC, a wholly owned subsidiary of Quality Systems, Inc., provides integrated clinical, financial and connectivity solutions for ambulatory, inpatient and dental provider organizations. For more information, please visit and . Follow NextGen Healthcare on Twitter at or Facebook at .